XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Apr. 03, 2021     50,869 0            
Balance at Apr. 03, 2021 $ 731,670 $ (60,121) $ 509 $ 0 $ 602,727 $ (61,156) $ 157,981 $ 1,035 $ (29,547) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Employee stock purchase plan (in shares)     39              
Employee stock purchase plan 2,210       2,210          
Exercise of stock options (in shares)     14              
Exercise of stock options 500   $ 0   500          
Issuance of restricted stock, net of cancellations (in shares)     91              
Issuance of restricted stock, net of cancellations 0   $ 1   (1)   0      
Share-based compensation expense 6,828       6,828          
Net income (loss) (4,454)           (4,454)      
Other comprehensive income (loss) 447           0   447  
Balance (in shares) at Jul. 03, 2021     51,013              
Balance at Jul. 03, 2021 677,080   $ 510   551,108   154,562   (29,100)  
Balance (in shares) at Apr. 02, 2022     51,124              
Balance at Apr. 02, 2022 749,424   $ 511   572,476   202,391   (25,954)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Employee stock purchase plan (in shares)     57              
Employee stock purchase plan 2,459       2,459          
Exercise of stock options (in shares)     3              
Exercise of stock options 127   $ 1   126          
Issuance of restricted stock, net of cancellations (in shares)     131              
Issuance of restricted stock, net of cancellations 0   $ 1   (1)          
Share-based compensation expense 5,299       5,299          
Net income (loss) 19,877           19,877      
Other comprehensive income (loss) (6,763)               (6,763)  
Balance (in shares) at Jul. 02, 2022     51,315              
Balance at Jul. 02, 2022 $ 770,423   $ 513   $ 580,359   $ 222,268   $ (32,717)